Skip to main content
Clinical Trials/NCT07270081
NCT07270081CompletedNot Applicable

Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEIDON Criteria

Instituto Bernabeu2 sites in 1 country40 target enrollmentStarted: January 1, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
40
Locations
2
Primary Endpoint
number of cumulus-oocyte complexes

Study Overview

Brief Summary

This is a prospective, randomized, controlled clinical trial designed to evaluate whether follicular flushing increases the number of cumulus-oocyte complexes (COCs) retrieved compared to single aspiration in patients with poor ovarian response belonging to Poseidon groups 3 and 4.

A total of 40 patients with poor ovarian response belonging to Poseidon groups 3 and 4 will be included. In each patient, one ovary will be randomized to the study technique (follicular flushing), and the other ovary will be randomized to the control technique (single aspiration).

Detailed Description

This is a prospective, randomized, controlled clinical study designed to evaluate the effect of follicular flushing on the number of cumulus-oocyte complexes (COCs) retrieved, compared to single aspiration, in patients with poor ovarian response classified as Poseidon groups 3 and 4.

A total of 40 patients will be included. All participants will receive a standardized stimulation protocol consistent with current practice for patients diagnosed with low ovarian reserve. After meeting all inclusion criteria, controlled ovarian stimulation will begin within the first four days of the menstrual cycle, using an antagonist protocol in all cases.

Starting on the 6th day of ovarian stimulation, daily administration of a GnRH antagonist at a dose of 0.25 mg (Ganirelix® or Cetrorelix®) will be initiated. Final oocyte maturation will be triggered once at least one follicle reaches a diameter of ≥17 mm, using either 250 μg of recombinant hCG (Ovitrelle®; Merck Serono) or 0.2 mg of triptorelin acetate (Decapeptyl®), or a double trigger. Oocyte retrieval will be performed 36 hours after triggering final oocyte maturation.

On the day of oocyte retrieval, randomization will be performed using a computer-generated randomization list. In each patient, one ovary will be randomly assigned to the control group (single aspiration), and the contralateral ovary will be assigned to the study group (follicular flushing). Simple random allocation will be used. Each patient will be allowed to participate in the study only once.

Oocyte retrieval procedures will be performed by four trained physicians to evaluate the reproducibility and generalizability of the technique. Follicles will be aspirated using 17G needles in both groups. For follicular flushing, the same needle model used for single aspiration (Cook) will be employed. To eliminate dead space, the needle will be prefilled with flushing medium before beginning the procedure. Aspiration pressure will be maintained at 190 mmHg during oocyte retrieval.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
— to 43 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pacientes con baja respuesta ovárica grupos POSEIDON 3 y 4 (< 35 años y RFA <5 y/o AMH < 1.2 ng/ml o > 35 años≥ 35 años y RFA <5 o AMH <1.2 ng/mL respectivamente)
  • Pacientes menores o igual a 43 años.
  • Índice de Masa Corporal (IMC) de 18-35 kg/m2
  • Estimulación ovárica para ICSI
  • Presencia y accesibilidad de ambos ovarios.
  • Ausencia de patología ovárica
  • Cuando se cumplan los criterios de desencadenamiento para la maduración final del ovocito, cada ovario debe contener al menos un folículo mayor o igual a 14 mm.
  • Haber dado su consentimiento por escrito.

Exclusion Criteria

  • Presence of a single ovary.
  • Presence of ovarian pathology.
  • Use of conventional IVF as the fertilization method.

Arms & Interventions

Single Aspiration Arm

Active Comparator

Oocytes will be retrieved from one ovary using single follicular aspiration

Intervention: follicular aspiration (Procedure)

Follicular Flushing Arm

Experimental

Oocytes will be retrieved from the contralateral ovary using follicular flushing, with up to three flushes per follicle if no cumulus-oocyte complex is obtained initially

Intervention: follicular flushing (Procedure)

Outcomes

Primary Outcomes

number of cumulus-oocyte complexes

Time Frame: During the egg retrieval

number of cumulus-oocyte complexes (COCs) retrieved after each aspiration

Secondary Outcomes

  • Oocyte recovery rate(day of the egg retrieval)
  • Fertilization rate(1 day after the egg retrieval)
  • Empty follicle rate(day of the egg retrieval)
  • Procedure time(In seconds from needle insertion to its withdrawal for each ovary)

Investigators

Sponsor
Instituto Bernabeu
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Paolo Cirillo

principal investigator

Instituto Bernabeu

Study Sites (2)

Loading locations...

Similar Trials